HLA Class I and Genetic Susceptibility to Type 1 Diabetes
Open accessAbstract
OBJECTIVE: We report here genotyping data and type 1 diabetes association analyses for HLA class I loci (A, B, and C) on 1,753 multiplex pedigrees from the Type 1 Diabetes Genetics Consortium (T1DGC), a large international collaborative study. RESEARCH DESIGN AND METHODS: Complete eight-locus HLA genotyping data were generated. Expected patient class I (HLA-A, -B, and -C) allele frequencies were calculated, based on linkage disequilibrium (LD) patterns with observed HLA class II DRB1-DQA1-DQB1 haplotype frequencies. Expected frequencies were compared to observed allele frequencies in patients. RESULTS: Significant type 1 diabetes associations were observed at all class I HLA loci. After accounting for LD with HLA class II, the most significantly type 1 diabetes–associated alleles were B*5701 (odds ratio 0.19; P = 4 × 10−11) and B*3906 (10.31; P = 4 × 10−10). Other significantly type 1 diabetes–associated alleles included A*2402, A*0201, B*1801, and C*0501 (predisposing) and A*1101, A*3201, A*6601, B*0702, B*4403, B*3502, C*1601, and C*0401 (protective). Some alleles, notably B*3906, appear to modulate the risk of all DRB1-DQA1-DQB1 haplotypes on which they reside, suggesting a class I effect that is independent of class II. Other class I type 1 diabetes associations appear to be specific to individual class II haplotypes. Some apparent associations (e.g., C*1601) could be attributed to strong LD to another class I susceptibility locus (B*4403). CONCLUSIONS: These data indicate that HLA class I alleles, in addition to and independently from HLA class II alleles, are associated with type 1 diabetes.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The HLA region on chromosome 6 (ie, the IDDM1 locus) provides perhaps one-half of the genetic susceptibility that leads to risk of type 1 diabetes.
“The HLA region on chromosome 6 (ie, the IDDM1 locus) provides perhaps one-half of the genetic susceptibility that leads to risk of type 1 diabetes.73”
From Type 1 diabetes (2014) · cites this paper as [73]
The introductory passage (labeled Abstract > CONCLUSIONS; page unavailable) identifies HLA loci on chromosome 6p21 as the major genetic susceptibility determinants for type 1 diabetes. Our copy does not quantify their contribution as approximately one-half or identify the region as IDDM1; searches for those terms and for a 50% contribution found no supporting passage. (LLM, conf=0.88)
Experimental — accuracy not yet measuredClass I MHCs also seem to influence risk for type 1 diabetes, independent of class II molecules.
“Class I MHCs also seem to influence risk for type 1 diabetes, independent of class II molecules.73”
From Type 1 diabetes (2014) · cites this paper as [73]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Migueles, S. A., Sabbaghian, M. S., Shupert, W. L., Bettinotti, M. P., Marincola, F. M., Martino, L., Hallahan, C. W., Selig, S. M., Schwartz, D. H., Sullivan, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050567397 · Cited by 995 · see citing works
HLA DR-DQ Haplotypes and Genotypes and Type 1 Diabetes Risk
Erlich, H., Valdes, A. M., Noble, J., Carlson, J. A., Varney, M., Concannon, P., Mychaleckyj, J. C., Todd, J. A., Bonella, P., Fear, A. L., et al. (2008) · Diabetes · doi:10.2337/db07-1331 · Cited by 790 · cited 4× · see citing works
“,(1) and references therein) and, to a lesser extent, HLA-DPB1/DPA1 (2-6).”
BackgroundMethodInfluentialSelf-citationLocalization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A
Nejentsev, S., Howson, J. M. M., Walker, N. M., Szeszko, J. S., Field, S. F., Stevens, H. E., Reynolds, P., Hardy, M. P., King, E., Masters, J., et al. (2007) · Nature · doi:10.1038/nature06406 · Cited by 568 · see citing works
Mapping disease genes: family-based association studies.
Thomson, G. (1995) · PubMed Central · Cited by 335 · see citing works
Macdonald, W. A., Purcell, A. W., Mifsud, N. A., Ely, L. K., Williams, D. S., Chang, L., Gorman, J. J., Clements, C. S., Kjer‐Nielsen, L., Koelle, D. M., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030066 · Cited by 204 · see citing works
Howson, J. M. M., Walker, N. M., Clayton, D. G., & Todd, J. A. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.01001.x · Cited by 132 · see citing works
The HLA class I A locus affects susceptibility to type 1 diabetes
Noble, J. A., Valdes, A. M., Bugawan, T. L., Apple, R. J., Thomson, G. J., & Erlich, H. A. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00421-4 · Cited by 128 · see citing works
Self-citationValdes, A. M., Erlich, H. A., & Noble, J. A. (2005) · Human Immunology · doi:10.1016/j.humimm.2004.12.001 · Cited by 119 · see citing works
Self-citationHLA DR antigens and susceptibility to insulin-dependent diabetes mellitus.
Thomson, G. (1984) · PubMed · Cited by 109 · see citing works
The HLA class II locus DPB1 can influence susceptibility to type 1 diabetes.
Noble, J. A., Valdes, A. M., Thomson, G., & Erlich, H. A. (2000) · Diabetes · doi:10.2337/diabetes.49.1.121 · Cited by 104 · see citing works
Self-citationMulti-SNP Analysis of MHC Region
Aly, T. A., Eller, E., Ide, A., Gowan, K., Babu, S. R., Erlich, H. A., Rewers, M., Eisenbarth, G. S., & Fain, P. R. (2006) · Diabetes · doi:10.2337/db05-1276 · Cited by 87 · see citing works
Self-citationHelmberg, W. M. C., Lanzer, G., Zahn, R., Weinmayr, B., Wagner, T., & Albert, E. D. (1998) · Tissue Antigens · doi:10.1111/j.1399-0039.1998.tb03000.x · Cited by 77 · see citing works
The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos
Bugawan, T. L., Klitz, W., Alejandrino, M., Ching, J. C. Y., Panelo, A., Solfelix, C., Petrone, A., Buzzetti, R., Pozzilli, P., & Erlich, H. A. (2002) · Tissue Antigens · doi:10.1034/j.1399-0039.2002.590602.x · Cited by 76 · see citing works
Self-citationCucca, F., Dudbridge, F., Miriam, L., Mulargia, A. P., Lampis, R., Angius, E., Virgiliis, S. D., Koeleman, B. P. C., Bain, S. C., Barnett, A. H., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1200 · Cited by 69 · see citing works
The Effect of HLA-B Allele on the IDDM Risk Defined by DRB1*04 Subtypes and DQB1*0302
Nejentsev, S., Reijonen, H., Adojaan, B., Kovalchuk, L., Sochnevs, A., Schwartz, E. I., Åkerblom, H. K., & Ilonen, J. (1997) · Diabetes · doi:10.2337/diab.46.11.1888 · Cited by 69 · see citing works
HLA genes associated with autoimmunity and progression to disease in type 1 diabetes
Tait, B. D., Colman, P. G., Morahan, G., Marchinovska, L., Doré, É., Gellert, S. A., Honeyman, M. C., Stephen, K., & Loth, A. (2003) · Tissue Antigens · doi:10.1034/j.1399-0039.2003.00013.x · Cited by 68 · see citing works
DPB1 Alleles Are Associated With Type 1 Diabetes Susceptibility in Multiple Ethnic Groups
Cruz, T. D., Valdes, A. M., Santiago, A., de Llado, T. F., Raffel, L. J., Zeidler, A., Rotter, J. I., Erlich, H. A., Rewers, M., Bugawan, T. L., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2158 · Cited by 50 · see citing works
Self-citationModeling of HLA class II susceptibility to Type I diabetes reveals an effect associated with DPB1
Valdes, A. M., Noble, J. A., Génin, E., Clerget‐Darpoux, F., Erlich, H. A., & Thomson, G. J. (2001) · Genetic Epidemiology · doi:10.1002/gepi.1030 · Cited by 34 · see citing works
Self-citationThe HLA-B/-C haplotype block contains major determinants for host control of HIV
Trachtenberg, E., Tanmoy Bhattacharya, A., Ladner, M. B., Phair, J., Erlich, H., & Wolinsky, S. M. (2009) · Genes and Immunity · doi:10.1038/gene.2009.58 · Cited by 28 · see citing works
Self-citationValdés, A., Thomson, G., & Barcellos, L. (2010) · Genes and Immunity · doi:10.1038/gene.2009.104 · Cited by 12 · see citing works
Self-citationAssociation of HLA-DPB1 alleles with type I diabetes mellitus in Slovak population
Stuchlíková, M., Kantárová, D., Michalková, D., Barák, Ľ., & Buc, M. (2006) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03656789 · Cited by 10 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,713 · see citing works
Cortés, A., Hadler, J. S., Robinson, P. C., Leo, P., Cremin, K., Pryce, K., Harris, J., Bradbury, L. A., Kenna, T., Yang, J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2667 · Cited by 855 · see citing works
Differentiation of diabetes by pathophysiology, natural history, and prognosis
Skyler, J. S., Bakris, G. L., Bonifacio, E., Darsow, T., Eckel, R. H., Groop, L., Groop, P.-H., Handelsman, Y., Insel, R. A., Mathieu, C., et al. (2017) · Diabetes · doi:10.2337/db16-0806 · Cited by 823 · see citing works
The heterogeneous pathogenesis of type 1 diabetes mellitus
Ilonen, J., Lempainen, J., & Veijola, R. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0254-y · Cited by 497 · see citing works
Genetics of the HLA Region in the Prediction of Type 1 Diabetes
Noble, J., & Valdés, A. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0223-x · Cited by 453 · see citing works
Self-citationAutoreactive T cells in type 1 diabetes
Pugliese, A. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94549 · Cited by 355 · see citing works
Oram, R. A., Patel, K. A., Hill, A., Shields, B. M., McDonald, T. J., Jones, A. G., Hattersley, A. T., & Weedon, M. N. (2015) · Diabetes Care · doi:10.2337/dc15-1111 · Cited by 351 · see citing works
Noble, J. A., & Erlich, H. A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007732 · Cited by 335 · see citing works
Self-citationMarine Algae-Derived Bioactive Compounds: A New Wave of Nanodrugs?
Menaa, F., Wijesinghe, U., Thiripuranathar, G., Althobaiti, N. A., Albalawi, A. E., Khan, B. A., & Menaa, B. (2021) · Marine Drugs · doi:10.3390/md19090484 · Cited by 247 · see citing works
Immunogenetics of type 1 diabetes: a comprehensive review
Noble, J. A. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.07.014 · Cited by 227 · see citing works
Self-citationRedondo, M. J., Steck, A. K., & Pugliese, A. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12597 · Cited by 216 · see citing works
Early prediction of autoimmune (type 1) diabetes.
Regnell, S. E., & Lernmark, Å. (2017) · Diabetologia · doi:10.1007/s00125-017-4308-1 · Cited by 195 · see citing works
Hussain, T., Tan, B., Murtaza, G., Liu, G., Rahu, N., Kalhoro, M. S., Kalhoro, D. H., Adebowale, T. O., Mazhar, M. U., Rehman, Z. U., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104629 · Cited by 202 · see citing works
Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy
Liblau, R., Vassalli, A., Seifinejad, A., & Tafti, M. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70218-2 · Cited by 189 · see citing works
The complement system and human autoimmune diseases
Coss, S. L., Zhou, D., Chua, G. T., Abdul‐Aziz, R., Hoffman, R. P., Wu, Y. L., Ardoin, S. P., Atkinson, J. P., & Yu, C. Y. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102979 · Cited by 189 · see citing works
Cannas, D., Loi, E., Serra, M., Firinu, D., Valera, P., & Zavattari, P. (2020) · Nutrients · doi:10.3390/nu12072074 · Cited by 169 · see citing works
Ilonen, J., Kiviniemi, M., Lempainen, J., Simell, O., Toppari, J., Veijola, R., Knip, M., & Register, T. F. P. D. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12327 · Cited by 134 · see citing works
Önengüt-Gümüşcü, S., Chen, W., Robertson, C. C., Bonnie, J. K., Farber, E., Zhu, Z., Oksenberg, J. R., Brant, S. R., Bridges, S. L., Edberg, J. C., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1727 · Cited by 129 · see citing works
Self-citationMolecular Mechanisms in Autoimmune Type 1 Diabetes: a Critical Review
Xie, Z., Chang, C., & Zhou, Z. (2014) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-014-8422-2 · Cited by 121 · see citing works
T-Cell Epitopes and Neo-epitopes in Type 1 Diabetes: A Comprehensive Update and Reappraisal
James, E. A., Mallone, R., Kent, S. C., & DiLorenzo, T. P. (2020) · Diabetes · doi:10.2337/dbi19-0022 · Cited by 112 · see citing works
Human islet T cells are highly reactive to preproinsulin in type 1 diabetes
Anderson, A. M., Landry, L. G., Alkanani, A. K., Pyle, L. L., Powers, A. C., Atkinson, M. A., Mathews, C. E., Roep, B. O., Michels, A. W., & Nakayama, M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2107208118 · Cited by 95 · see citing works
Immune Recognition of β-Cells: Neoepitopes as Key Players in the Loss of Tolerance
James, E. A., Pietropaolo, M., & Mamula, M. J. (2018) · Diabetes · doi:10.2337/dbi17-0030 · Cited by 94 · see citing works
Type 1 Diabetes Mellitus: Cellular and Molecular Pathophysiology at A Glance.
Saberzadeh-Ardestani, B., Karamzadeh, R., Basiri, M., Hajizadeh‐Saffar, E., Farhadi, A., Shapiro, A. M. J., Tahamtani, Y., & Baharvand, H. (2018) · Europe PMC (PubMed Central) · doi:10.22074/cellj.2018.5513 · Cited by 88 · see citing works
Systematic Review of Polygenic Risk Scores for Type 1 and Type 2 Diabetes
Padilla-Martínez, F., Collin, F., Kwaśniewski, M., & Kretowski, A. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051703 · Cited by 86 · see citing works
Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases
Guerra, J. V. D. S., Dias, M. M. G., Brilhante, A. J. V. C., Terra, M. F., García‐Arévalo, M., & Figueira, A. C. M. (2021) · Nutrients · doi:10.3390/nu13082830 · Cited by 87 · see citing works
Narcolepsy-Associated HLA Class I Alleles Implicate Cell-Mediated Cytotoxicity
Tafti, M., Lammers, G. J., Dauvilliers, Y. A., Overeem, S., Mayer, G., Nowak, J., Pfister, C., Dubois, V., Eliaou, J., Eberhard, H., et al. (2016) · SLEEP · doi:10.5665/sleep.5532 · Cited by 84 · see citing works
Innate inflammation in type 1 diabetes
Cabrera, S. M., Henschel, A. M., & Hessner, M. J. (2015) · Translational research · doi:10.1016/j.trsl.2015.04.011 · Cited by 84 · see citing works
Perry, D. J., Wasserfall, C. H., Oram, R. A., Williams, M. D., Posgai, A. L., MUIR, A. B., Haller, M. J., Schatz, D., Wallet, M. A., Mathews, C. E., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22574-5 · Cited by 84 · see citing works
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis
Invernizzi, P., Ransom, M., Raychaudhuri, S., Kosoy, R., Lleò, A., Shigeta, R., Franke, A., Bossa, F., Amos, C. I., Gregersen, P. K., et al. (2012) · Genes and Immunity · doi:10.1038/gene.2012.17 · Cited by 83 · see citing works
Alvarez‐Navarro, C., & de Castro, J. A. Ł. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.06.012 · Cited by 82 · see citing works
Impact of hyperglycemia on immune cell function: a comprehensive review
Lee, H., Kim, M.-J., Lee, I.-K., Hong, C.-W., & Jeon, J. (2024) · Diabetology International · doi:10.1007/s13340-024-00741-6 · Cited by 90 · see citing works
Stem-cell based organ-on-a-chip models for diabetes research
Rogal, J., Zbinden, A., Schenke‐Layland, K., & Loskill, P. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.010 · Cited by 83 · see citing works
The genetic architecture of type 1 diabetes mellitus
Nyaga, D. M., Vickers, M. H., Jefferies, C., Perry, J. K., & O'Sullivan, J. M. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.06.002 · Cited by 79 · see citing works
T Cell Epitopes and Post-Translationally Modified Epitopes in Type 1 Diabetes
McGinty, J. W., Marré, M. L., Bajzik, V., Piganelli, J. D., & James, E. A. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0657-7 · Cited by 77 · see citing works
Seldin, M. F., Alkhairy, O. K., Lee, A. T., Lamb, J. A., Sussman, J. D., Pirskanen, R., Piehl, F., Verschuuren, J. J. G. M., Kostera‐Pruszczyk, A., Szczudlik, P., et al. (2015) · Molecular Medicine · doi:10.2119/molmed.2015.00232 · Cited by 75 · see citing works
Metabolic Diseases and Down Syndrome: How Are They Linked Together?
Moreau, M., Benhaddou, S., Dard, R., Tolu, S., Hamzé, R., Vialard, F., Movassat, J., & Janel, N. (2021) · Biomedicines · doi:10.3390/biomedicines9020221 · Cited by 75 · see citing works
Beyond the Hormone: Insulin as an Autoimmune Target in Type 1 Diabetes
Brezar, V., Carel, J., Boîtard, C., & Mallone, R. (2011) · Endocrine Reviews · doi:10.1210/er.2011-0010 · Cited by 66 · see citing works
The pancreatic β cell and type 1 diabetes: innocent bystander or active participant?
Soleimanpour, S. A., & Stoffers, D. A. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.03.005 · Cited by 60 · see citing works
What the HLA-I!—Classical and Non-classical HLA Class I and Their Potential Roles in Type 1 Diabetes
Wyatt, R. C., Lanzoni, G., Russell, M. A., Gerling, I., & Richardson, S. J. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1245-z · Cited by 59 · see citing works
Hypomethylation within gene promoter regions and type 1 diabetes in discordant monozygotic twins
Elboudwarej, E., Cole, M. B., Briggs, F. B. S., Fouts, A., Fain, P. R., Quach, H., Quach, D. L., Sinclair, E., Criswell, L. A., Lane, J. A., et al. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.12.003 · Cited by 57 · see citing works
Self-citationGenetic Epidemiology of Type 1 Diabetes in the 22 Arab Countries
Zayed, H. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0736-4 · Cited by 56 · see citing works
The Role of β Cell Stress and Neo-Epitopes in the Immunopathology of Type 1 Diabetes
Piganelli, J. D., Mamula, M. J., & James, E. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.624590 · Cited by 54 · see citing works
The Immunoproteasome: An Emerging Target in Cancer and Autoimmune and Neurological Disorders
Zerfas, B. L., Maresh, M. E., & Trader, D. J. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01226 · Cited by 53 · see citing works
Using the T Cell Receptor as a Biomarker in Type 1 Diabetes
Nakayama, M., & Michels, A. W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.777788 · Cited by 48 · see citing works
Next Generation Sequencing Reveals the Association of DRB3*02:02 With Type 1 Diabetes
Erlich, H., Valdés, A., McDevitt, S., Simen, B., Blake, L., McGowan, K. R., Todd, J., Rich, S., & Noble, J. (2013) · Diabetes · doi:10.2337/db12-1387 · Cited by 49 · see citing works
Self-citationO’Kell, A. L., Wasserfall, C. H., Catchpole, B., Davison, L. J., Hess, R. S., Kushner, J. A., & Atkinson, M. A. (2017) · Diabetes · doi:10.2337/db16-1551 · Cited by 51 · see citing works
Carré, A., Richardson, S. J., Larger, É., & Mallone, R. (2020) · Diabetologia · doi:10.1007/s00125-020-05298-y · Cited by 51 · see citing works
Origin and plasticity of MHC I-associated self peptides
de Verteuil, D. A., Granados, D. P., Thibault, P., & Perreault, C. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.11.003 · Cited by 48 · see citing works
Hollenbach, J. A., Mack, S. J., Gourraud, P., Single, R. M., Maiers, M. J., Middleton, D., Thomson, G., Marsh, S. G. E., Varney, M. D., & for the Immunogenomics Data Analysis Working Group (2011) · Tissue Antigens · doi:10.1111/j.1399-0039.2011.01777.x · Cited by 47 · see citing works
Self-citationGenetic Aspects of type 1 diabetes
Lee, H. S., & Hwang, J. S. (2019) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2019.24.3.143 · Cited by 46 · see citing works
Mikk, M.-L., Kiviniemi, M., Laine, A., Härkönen, T., Veijola, R., Simell, O., Knip, M., & Ilonen, J. (2014) · Human Immunology · doi:10.1016/j.humimm.2013.09.008 · Cited by 43 · see citing works
Törn, C., Liu, X., Hagopian, W., Lernmark, Å., Simell, O., Rewers, M., Ziegler, A., Schatz, D., Akolkar, B., Önengüt-Gümüşcü, S., et al. (2016) · Scientific Reports · doi:10.1038/srep27887 · Cited by 39 · see citing works
Metabolic Syndrome After HIV Acquisition in South African Women
Sobieszczyk, M. E., Werner, L., Mlisana, K. P., Naicker, N., Feinstein, A., Gray, C. M., Masson, L., Passmore, J.-A. S., Williamson, C. E., Karim, Q. A., et al. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001123 · Cited by 43 · see citing works
Fath, M. K., Jahangiri, A., Ganji, M., Sefid, F., Payandeh, Z., Hashemi, Z. S., Pourzardosht, N., Hessami, A., Mard‐Soltani, M., Zakeri, A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.705772 · Cited by 40 · see citing works
Valdés, A., Erlich, H. A., Carlson, J., Varney, M., Moonsamy, P. V., & Noble, J. A. (2012) · Diabetologia · doi:10.1007/s00125-012-2608-z · Cited by 40 · see citing works
Self-citationNoble, J. A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1457213 · Cited by 42 · see citing works
Self-citationClinical and research uses of genetic risk scores in type 1 diabetes
Sharp, S. A., Weedon, M. N., Hagopian, W., & Oram, R. A. (2018) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2018.03.009 · Cited by 40 · see citing works
Cantú-Rodríguez, O. G., Lavalle-González, F., Herrera-Rojas, M. Á., Jaime-Pérez, J. C., Hawing-Zárate, J. Á., Gutiérrez-Aguirre, C. H., Mancias-Guerra, C., González-Llano, O., Zapata-Garrido, A., Villarreal-Pérez, J. Z., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2776 · Cited by 39 · see citing works
Genetic Discrimination Between LADA and Childhood-Onset Type 1 Diabetes Within the MHC
Mishra, R., Åkerlund, M., Cousminer, D. L., Ahlqvist, E., Bradfield, J. P., Chesi, A., Hodge, K. M., Guy, V. C., Brillon, D. J., Pratley, R. E., et al. (2020) · Diabetes Care · doi:10.2337/dc19-0986 · Cited by 46 · see citing works
Gene-environment interaction in the pathophysiology of type 1 diabetes
Mittal, R., Camick, N., Lemos, J. R. N., & Hirani, K. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1335435 · Cited by 46 · see citing works
Critical Review of Existing MHC I Immunopeptidome Isolation Methods
Kuznetsov, A. A., Voronina, A. K., Govorun, V. M., & Arapidi, G. P. (2020) · Molecules · doi:10.3390/molecules25225409 · Cited by 37 · see citing works
Nathan, B. M., REDONDO, M. J., Ismail, H. M., Jacobsen, L. M., Sims, E. K., Palmer, J. P., Skyler, J. S., Bocchino, L. E., Geyer, S. M., & Sosenko, J. M. (2021) · Diabetes Care · doi:10.2337/dc21-0944 · Cited by 36 · see citing works
Yeo, L., Pujol‐Autonell, I., Baptista, R., Eichmann, M., Kronenberg‐Versteeg, D., Heck, S., Dolton, G. M., Sewell, A. K., Härkönen, T., Mikk, M.-L., et al. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13391 · Cited by 35 · see citing works
MECHANISMS IN ENDOCRINOLOGY: Insulin and type 1 diabetes: immune connections
Čulina, S., Brezar, V., & Mallone, R. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0693 · Cited by 33 · see citing works
Roshandel, D., Gubitosi‐Klug, R., Bull, S. B., Canty, A. J., Pezzolesi, M. G., King, G. L., Keenan, H. A., Snell‐Bergeon, J. K., Maahs, D. M., Klein, R., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4555-9 · Cited by 33 · see citing works
Sintilimab-Induced Autoimmune Diabetes in a Patient With the Anti-tumor Effect of Partial Regression
Wen, L., Zou, X.-W., Chen, Y., Bai, X., & Liang, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02076 · Cited by 32 · see citing works
Humanized Mouse Model to Study Type 1 Diabetes
Luce, S., Guinoiseau, S., Gadault, A., Letourneur, F., Blondeau, B., Nitschké, P., Pasmant, É., Vidaud, M., Lemonnier, F. A., & Boîtard, C. (2018) · Diabetes · doi:10.2337/db18-0202 · Cited by 31 · see citing works
Multiple HLA Epitopes Contribute to Type 1 Diabetes Susceptibility
Roark, C. L., Anderson, K. M., Simon, L., Schuyler, R. P., Aubrey, M., & Freed, B. (2013) · Diabetes · doi:10.2337/db13-1153 · Cited by 34 · see citing works
Gjymishka, A., Coman, R. M., Brusko, T. M., & Glover, S. C. (2013) · Immunotherapy · doi:10.2217/imt.13.130 · Cited by 30 · see citing works
Index60 as an additional diagnostic criterion for type 1 diabetes
REDONDO, M. J., Nathan, B. M., Jacobsen, L. M., Sims, E. K., Bocchino, L. E., Pugliese, A., Schatz, D., Atkinson, M. A., Skyler, J. S., Palmer, J. P., et al. (2021) · Diabetologia · doi:10.1007/s00125-020-05365-4 · Cited by 30 · see citing works
Mallone, R., Scotto, M., Janicki, C. N., James, E. A., Fitzgerald-Miller, L., Wagner, R., Gottlieb, P. A., Thorpe, J., Jospe, N., Durinovic‐Belló, I., et al. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1243 · Cited by 29 · see citing works
Fitas, A. L., Martins, C. G., Borrego, L. M., Lopes, L., Jörns, A., Lenzen, S., & Limbert, C. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12671 · Cited by 29 · see citing works
Progress and challenges for treating Type 1 diabetes
Garyu, J., Meffre, E., Cotsapas, C. J., & Herold, K. C. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.04.004 · Cited by 28 · see citing works
Targeting Glycoproteins as a therapeutic strategy for diabetes mellitus and its complications
Naseri, R., Navabi, S. J., Samimi, Z., Mishra, A. P., Nigam, M., Chandra, H., Olatunde, A., Tijjani, H., Morais‐Urano, R. P., & Farzaei, M. H. (2020) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-020-00327-y · Cited by 30 · see citing works
Genetics Coming of Age in Type 1 Diabetes
Cerolsaletti, K., Hao, W., & Greenbaum, C. J. (2019) · Diabetes Care · doi:10.2337/dci18-0039 · Cited by 28 · see citing works
Significance of KIR like natural killer cell receptors in autoimmune disorders
Agrawal, S., & Prakash, S. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108449 · Cited by 27 · see citing works
Eichmann, M., de Ru, A., van Veelen, P. A., Peakman, M., & Kronenberg‐Versteeg, D. (2014) · Tissue Antigens · doi:10.1111/tan.12413 · Cited by 27 · see citing works
Mbunwe, E., der Auwera, B. J. R. V., Vermeulen, I., Demeester, S., Dalem, A. V., Balti, E. V., Aken, S. V., Derdelinckx, L., Dorchy, H., Schepper, J. D., et al. (2012) · Diabetes · doi:10.2337/db12-0747 · Cited by 27 · see citing works
Yang, K., Zhang, Y., Ding, J., Li, Z., Zhang, H., & Zou, F. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1377322 · Cited by 28 · see citing works
Aydemir, Ö., Noble, J. A., Bailey, J. A., Lernmark, Å., Marsh, P. W., Svärd, A. A., Bearoff, F. M., Blankenhorn, E. P., Mordes, J. P., Better Diabetes Diagnosis (BDD) Study Group, et al. (2019) · Diabetes · doi:10.2337/db18-1128 · Cited by 26 · see citing works
Self-citationMikk, M., Heikkinen, T., El‐Amir, M. I., Kiviniemi, M., Laine, A., Härkönen, T., Veijola, R., Toppari, J., Knip, M., Ilonen, J., et al. (2017) · HLA · doi:10.1111/tan.12967 · Cited by 26 · see citing works
Schloss, J. M., Ali, R., Racine, J. J., Chapman, H. D., SERREZE, D. V., & DiLorenzo, T. P. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701652 · Cited by 25 · see citing works
Failed Genetic Protection: Type 1 Diabetes in the Presence of HLA-DQB1*06:02
Simmons, K. M., Mitchell, A. M., Alkanani, A. K., McDaniel, K. A., Baschal, E. E., Armstrong, T., Pyle, L. L., Yu, L., & Michels, A. W. (2020) · Diabetes · doi:10.2337/db20-0038 · Cited by 26 · see citing works
Jiang, Z., Ren, W., Liang, H., Yan, J., Yang, D., Luo, S., Zheng, X., Lin, G.-W., Xian, Y., Xu, W., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05476-6 · Cited by 26 · see citing works
Self-citationWilliams, C. L., Fareed, R., Mortimer, G., Aitken, R. J., Wilson, I. V., George, G., Gillespie, K. M., Williams, A. J. K., The BOX Study Group, Ballav, C., et al. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac087 · Cited by 25 · see citing works
The HLA-B*3906 allele imparts a high risk of diabetes only on specific HLA-DR/DQ haplotypes
Baschal, E. E., Baker, P. R., Eyring, K. R., Siebert, J., Jasinski, J., & Eisenbarth, G. S. (2011) · Diabetologia · doi:10.1007/s00125-011-2161-1 · Cited by 25 · see citing works
Racine, J. J., Stewart, I., Ratiu, J. J., Christianson, G. J., Lowell, E., Helm, K., Allocco, J., Maser, R. S., Chen, Y., Lutz, C. M., et al. (2018) · Diabetes · doi:10.2337/db17-1467 · Cited by 25 · see citing works
Race-Specific Type 1 Diabetes Risk of HLA-DR7 Haplotypes
Noble, J., Johnson, J., Lane, J. A., & Valdés, A. (2011) · Tissue Antigens · doi:10.1111/j.1399-0039.2011.01772.x · Cited by 26 · see citing works
Self-citationType 1 diabetes mellitus in pediatric age group
Pasi, R., & Ravi, K. S. (2022) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_975_21 · Cited by 25 · see citing works
Adaptive immune regulation in autoimmune diabetes
Ferretti, C., & Cava, A. L. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.11.008 · Cited by 23 · see citing works
Balke, E. M., Balti, E. V., der Auwera, B. J. R. V., Weets, I., Costa, O. R., Demeester, S., Abrams, P. J., Casteels, K., Coeckelberghs, M., Tenoutasse, S., et al. (2018) · Diabetes Care · doi:10.2337/dc17-2462 · Cited by 23 · see citing works
Discordant association of islet autoantibodies with high‐risk HLA genes in Chinese type 1 diabetes
Gu, Y., Zhang, M., Chen, H., Wang, Z., Xing, C., Yang, H., Xu, X., Liu, Y., Zhou, Z., Yu, L., et al. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1270 · Cited by 23 · see citing works
Ali, A. A., Aalto, M., Jonasson, J., & Osman, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-62645-0 · Cited by 22 · see citing works
Scotto, M., Afonso, G., Østerbye, T., Larger, É., Luce, S., Raverdy, C., Novelli, G., Bruno, G., Gonfroy‐Leymarie, C., Launay, O., et al. (2012) · Diabetes · doi:10.2337/db12-0136 · Cited by 22 · see citing works
Microsatellite variation in the equine MHC
Brinkmeyer‐Langford, C., Cai, J. J., Gill, C. A., & Skow, L. C. (2012) · Animal Genetics · doi:10.1111/age.12003 · Cited by 22 · see citing works
James, E. A., Abreu, J. R. F., McGinty, J. W., Odegard, J., Fillié, Y. E., Hocter, C. N., Čulina, S., Ladell, K., Price, D. A., Alkanani, A. K., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4508-8 · Cited by 22 · see citing works
Bratt, G., Brännström, J., Missalidis, C., & Nyström, T. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254079 · Cited by 21 · see citing works
The Multifactorial Progression from the Islet Autoimmunity to Type 1 Diabetes in Children
Bauer, W., Gyenesei, A., & Kretowski, A. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147493 · Cited by 24 · see citing works
Xu, X., Gu, Y., Bian, L., Shi, Y., Cai, Y., Chen, Y., Chen, H., Li, Q., Wu, X., Xu, K., et al. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.10.108 · Cited by 21 · see citing works
Long, A. E., Gillespie, K. M., Aitken, R. J., Goode, J. C., Bingley, P. J., & Williams, A. J. K. (2013) · Diabetes · doi:10.2337/db12-1468 · Cited by 21 · see citing works
- Authors
- Noble, J. A., Valdes, A. M., Varney, M. D., Carlson, J. A., Moonsamy, P., Fear, A. L., Lane, J. A., Lavant, E., Rappner, R., Louey, A., Concannon, P., Mychaleckyj, J. C., Erlich, H. A., & for the Type 1 Diabetes Genetics Consortium
- Affiliations
- Children's Hospital Oakland Research Institute, Oakland, California;
- King's College London (GB)
- Australian Red Cross Lifeblood (AU)
- Skåne University Hospital (SE)
- Roche Molecular Systems, Pleasanton, California;
- University of Virginia (US)
- Corresponding author
- Noble, Janelle A.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2010-08-26
- Volume
- 59
- Issue
- 11
- Pages
- 2972-2979
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2963558
- OpenAlex
- W2110458118
- Cited by
- 254
- References
- 21
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 31 · 2023: 12 · 2022: 9 · 2021: 30 · 2020: 22 · 2019: 17 · 2018: 25 · 2017: 11 · 2016: 14 · 2015: 17 · 2014: 8 · 2013: 20 · 2012: 14
- FWCI
- 8.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Juvenile Diabetes Research Foundation International (U01 DK062418)
- National Human Genome Research Institute
- National Institute of Allergy and Infectious Diseases
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK061722, R01 DK-61722, DK062418, U01DK062418)
- National Institute of Child Health and Human Development
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Keywords
- type 1 diabetes, HLA class I, HLA-A, HLA-B, HLA-C, genetic susceptibility, HLA class II, linkage disequilibrium, HLA-B*57:01, multiplex pedigrees, allele frequency
- MeSH terms
- Diabetes Mellitus, Type 1, Exons, Female, Gene Frequency, Humans, Male, Polymorphism, Genetic, T-Lymphocytes, HLA-A Antigens, HLA-B Antigens, HLA-C Antigens, Histocompatibility Antigens Class I, Linkage Disequilibrium, Genetic Predisposition to Disease, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
